These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18460929)

  • 1. Therapy and clinical trials.
    Duttaroy AK; Ray TK
    Curr Opin Lipidol; 2008 Jun; 19(3):330-2. PubMed ID: 18460929
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 3. Goals for cholesterol lowering.
    Stankler L
    Circulation; 1999 May; 99(18):2477. PubMed ID: 10318741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 5. From the editor: what are the important questions for clinical trials?
    Brown WV
    J Clin Lipidol; 2012; 6(4):299-300. PubMed ID: 22836064
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular pharmacology: opportunities for intervention.
    Keiser J
    Clin Pharmacol Ther; 2009 Aug; 86(2):124-6. PubMed ID: 19621004
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient profile: secondary prevention.
    Hobbs FD
    Int J Clin Pract Suppl; 2002 Jul; (130):13-4. PubMed ID: 12296601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
    Maki KC; McKenney JM; Reeves MS; Lubin BC; Dicklin MR
    Am J Cardiol; 2008 Aug; 102(4):429-33. PubMed ID: 18678300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins. Cholesterol treatment and beyond.
    Mayo Clin Health Lett; 2004 Nov; 22(11):1-3. PubMed ID: 15619748
    [No Abstract]   [Full Text] [Related]  

  • 11. Can cholesterol lowering be too aggressive?
    Johns Hopkins Med Lett Health After 50; 1999 Aug; 11(6):3. PubMed ID: 10453711
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiology patient page. Measurement of cholesterol: a patient perspective.
    Birtcher KK; Ballantyne CM
    Circulation; 2004 Sep; 110(11):e296-7. PubMed ID: 15364820
    [No Abstract]   [Full Text] [Related]  

  • 13. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormones and... many symptoms of menopause means many therapies.
    Levine S; Brink S; Hobson K; Carpenter B; Malrine A
    US News World Rep; 2002 Nov; 133(19):63, 67-70. PubMed ID: 12501477
    [No Abstract]   [Full Text] [Related]  

  • 15. HDL: back to the drawing board.
    Johns Hopkins Med Lett Health After 50; 2007 May; 19(3):1-2. PubMed ID: 17657883
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rosuvastatin on methionine-induced hyperhomocysteinaemia and haematological changes in rats.
    Nigam GK; Ansari MN; Bhandari U
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):287-92. PubMed ID: 18684217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the editor: selling the benefit of drug therapy.
    Brown WV
    J Clin Lipidol; 2013; 7(1):1-2. PubMed ID: 23351576
    [No Abstract]   [Full Text] [Related]  

  • 20. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
    Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
    Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.